MMMario Melis

Mario Melis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mario Melis has a total of 123 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • An overview of the role of T cells in controlling tuberculosis infection in a pediatric population

    by Amelia Romano, Mario Melis, Luisa Abbagnato, Nadia Caccamo, Serena Meraviglia, Francesco Dieli, Paola Di Carlo

    The most significant immunological studies of tuberculosis (TB) infection have involved adult patients. Few studies about the immune repertoire have been conducted in children. The purpose of this paper is to focus on cellular immune response to Mycobacterium tuberculosis by reviewing our studies conducted on children with different forms of TB infection between 1998 and 2006. Although the gold standard of TB diagnosis remains isolation of TB bacillus that also allows estimation of pattern of resistance of M. tuberculosis, the study of immune response can be useful for the early diagnosis and therapeutic follow-up of pediatric TB.

  • Open Access

    An Elevated Body Mass Index Increases Lung Volume but Reduces Airflow in Italian Schoolchildren

    by Fabio Cibella, Andreina Bruno, Giuseppina Cuttitta, Salvatore Bucchieri, Mario Raphael Melis, Stefano De Cantis, Stefania La Grutta, Giovanni Viegi

    Asthma and obesity are important and growing health issues worldwide. Obesity is considered a risk factor for asthma, due to the induction of changes in airway mechanics and altered airway inflammation. We cross-sectionally investigated the effect of increased weight on pulmonary function in a large population sample of healthy children, aged 10–17 yrs living in Palermo, Italy. Explanatory effect of weight on lung function variables were evaluated by multiple linear regression models, taking into account height, gender, and age-class. Among the 2,393 subjects, FVC and FEV1 were positively correlated to weight. Multiple regression models showed that the weight beta coefficient for FEV1 was significantly lower with respect to that for FVC (0.005 and 0.009 l/kg, respectively), indicating a different magnitude in explanatory effect of weight on FVC and FEV1. Both FEV1/FVC and FEF25–75%/FVC ratios were negatively correlated to weight, while FEF25–75% was not significantly correlated. Similar results were obtained also when 807 symptomatic subjects were introduced in the model through a sensitivity analysis. In healthy children, the disproportionate increase of FEV1 and FVC with weight produces airflow decrease and consequently apparent poorer lung function independently from respiratory disease status.


  • Effect of indoor nitrogen dioxide on lung function in urban environment

    by Fabio Cibella, Giuseppina Cuttitta, Roberto Della Maggiore, Silvia Ruggieri, Simona Panunzi, Andrea De Gaetano, Salvatore Bucchieri, Gaspare Drago, Mario R. Melis, Stefania La Grutta, et al.


  • Open Access

    The Burden of Rhinitis and Rhinoconjunctivitis in Adolescents

    by Fabio Cibella, Giuliana Ferrante, Giuseppina Cuttitta, Salvatore Bucchieri, Mario R Melis, Stefania La Grutta, Giovanni Viegi

    Cibella F, et al. Allergy Asthma Immunol Res. 2015 Jan;7(1):44-50. https://doi.org/10.4168/aair.2015.7.1.44


  • An allergen-polymeric nanoaggregate as a new tool for allergy vaccination

    by Mariano Licciardi, Giovanna Montana, Maria Luisa Bondì, Angela Bonura, Cinzia Scialabba, Mario Melis, Calogero Fiorica, Gaetano Giammona, Paolo Colombo


  • Rhinitis as a risk factor for depressive mood in pre‐adolescents: a new approach to this relationship

    by Palma Audino, Stefania La Grutta, Fabio Cibella, Mario R. Melis, Salvatore Bucchieri, Pietro Alfano, Salvatore Marcantonio, Giuseppina Cuttitta

    Background: Respiratory allergic symptoms impact on social life and school activities, influencing the patient's mood states. We evaluated the relationships between allergic respiratory diseases and depressive/anxious mood in a large sample ofItalian middle school students, using the partial directed acyclic graph (P‐DAG).Methods: We studied 1283 subjects aged 10–13. A health respiratory questionnaire including questions relevant to socioeconomic status (HCI) and a test for depression and anxiety were administered. All subjects performed spirometry and skin prick tests.Results: A causal role of rhinitis on depression was found: the likelihood of being depressed increased from 11.2 to 17.7%, when rhinitis was present. Moreover, a direct effect of lowHCIon depressive mood was shown (p < 0.0001) as well as the correlation between anxiety and depression (p < 0.0001). Gender was not a direct causal factor for depressive mood, but their relation was mediated through anxious mood. Anxiety appeared to have a stronger association with depression than gender. Allergic sensitization was significantly related to both asthma and rhinitis (p < 0.0001, respectively). Asthma and rhinitis were also directly associated (p < 0.0001). Conversely, asthma was not directly associated with depressive mood, but their relation was mediated through rhinitis.Body mass index (BMI) and impaired lung function (IPF) were not associated with the other variables.Conclusions: The use of this novel approach to analyzing the dynamic relationships allowed us to find a causal role of rhinitis on depressive state. Moreover, anxious condition and low socioeconomic status contributed to induce depressive mood.


  • Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing

    by Liboria Siena, Elisabetta Pace, Maria Ferraro, Caterina Di Sano, Mario Melis, Mirella Profita, Mario Spatafora, Mark Gjomarkaj

    Gemcitabine is a chemotherapy agent commonly used in the treatment of non-small cell lung cancer (NSCLC) that has been demonstrated to induce apoptosis in NSCLC cells by increasing functionally active Fas expression. The aim of this study was to evaluate the Fas/Fas ligand (FasL) system involvement in gemcitabine-induced lung cancer cell killing. NSCLC H292 cells were cultured in the presence or absence of gemcitabine. FasL mRNA and protein were evaluated by real-time PCR, and by Western blot and flow cytometry, respectively. Apoptosis of FasL-expressing cells was evaluated by flow cytometry, and caspase-8 and caspase-3 activation by Western blot and a colorimetric assay. Cytotoxicity of lymphokine-activated killer (LAK) cells and malignant pleural fluid lymphocytes against H292 cells was analysed in the presence or absence of the neutralizing anti-Fas ZB4 antibody, by flow cytometry. Gemcitabine increased FasL mRNA and total protein expression, the percentage of H292 cells bearing membrane-bound FasL (mFasL) and of mFasL-positive apoptotic H292 cells, as well as caspase-8 and caspase-3 cleavage. Moreover, gemcitabine increased CH11-induced caspase-8 and caspase-3 cleavage and proteolytic activity. Cytotoxicity of LAK cells and pleural fluid lymphocytes was increased against gemcitabine-treated H292 cells and was partially inhibited by ZB4 antibody. These results demonstrate that gemcitabine: (i) induces up-regulation of FasL in lung cancer cells triggering cell apoptosis via an autocrine/paracrine loop; (ii) induces a Fas-dependent apoptosis mediated by caspase-8 and caspase-3 activation; (iii) enhances the sensitivity of lung cancer cells to cytotoxic activity of LAK cells and malignant pleural fluid lymphocytes, partially via Fas/FasL pathway. Our data strongly suggest an active involvement of the Fas/FasL system in gemcitabine-induced lung cancer cell killing.


  • Innate and adaptive immune responses to the major Parietaria allergen Par j 1 in healthy subjects

    by A. Bonura, S. Quaratino, F. Gervasi, M.R. Melis, C. Di Sano, P. Colombo


  • Characterization of a Par j 1/Par j 2 mutant hybrid with reduced allergenicity for immunotherapy of Parietaria allergy

    by A. Bonura, R. Passantino, M. A. Costa, G. Montana, M. Melis, M. Luisa Bondì, C. Butteroni, B. Barletta, S. Corinti, G. Di Felice, et al.

    Summary: Background: Parietaria pollen is one of the major cause of pollinosis in the southern Europe. Specific immunotherapy is the only treatment able to modify the natural outcome of the disease restoring a normal immunity against allergens.Methods: We designed a recombinant molecule (PjEDloop1) comprised of genetic‐engineered variants of the major allergens of the Parietaria pollen (Par j 2/Par j 1). Purity and chemical–physical properties of the derivative were analysed by RP‐HPLC chromatography and Photon Correlation Spectroscopy. Immunological activity was evaluated by means of Western blotting, ELISA inhibition and PBMC proliferation assay in 10 Parietaria allergic patients. Basophil activation was studied in six subjects. The immunogenicity of the hybrid was studied looking at the immune responses induced in a mouse model of sensitization.Results: The PjEDloop1 hybrid was produced as a purified recombinant protein with high stability in solution. Western blot, ELISA inhibition and basophil activation test showed that the PjEDloop1 displays a remarkable reduced IgE binding and anaphylactic activity. CD3 reactivity was conserved in all patients. Mice immunization with the rPjEDloop1 induced antibodies and T cell responses comparable to that obtained by the wild type allergens. Such antibodies shared the specificities to rPar j 1 and rPar j 2 with human IgE antibodies.Conclusion: Our results demonstrated that a mutant hybrid expressing genetically engineered forms of the major P. judaica allergens displayed reduced allergenicity and retained T cell reactivity for the induction of protective antibodies in vaccination approaches for the treatment of Parietaria pollinosis.


  • Open Access

    Lymphocyte apoptosis in children with central nervous system tuberculosis: a case control study

    by Paola Di Carlo, Alessandra Casuccio, Amelia Romano, Daria Spicola, Lucina Titone, Nadia Caccamo, Francesco Dieli, Caterina Mammina, Elisabetta Pace, Mark Gjomarkaj, et al.

    Studies of the apoptosis mechanisms involved in the pathogenesis of tuberculosis have suggested that Mycobacterium tuberculosis can actively interfere with the apoptosis of infected cells. In vivo studies have been performed in adult populations but have not focused on this process in children. In the present study, we analyzed spontaneous T lymphocyte (PBT) apoptosis in the peripheral blood of children with central nervous system tuberculosis (CNS TB), before and after chemotherapy, and compared the results with healthy controls.